Next Article in Journal
Advances and Challenges in Studying Hepatitis B Virus In Vitro
Next Article in Special Issue
To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses
Previous Article in Journal
Defining the Enterovirus Diversity Landscape of a Fecal Sample: A Methodological Challenge?
Previous Article in Special Issue
Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade
Article Menu

Export Article

Open AccessArticle
Viruses 2016, 8(1), 20; doi:10.3390/v8010020

Features of the Antitumor Effect of Vaccinia Virus Lister Strain

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences (ICBFM SB RAS), 8 Lavrentiev Avenue, Novosibirsk 630090, Russia
State Research Center of Virology and Biotechnology “Vector”, Koltsovo 630559, Russia
Author to whom correspondence should be addressed.
Academic Editors: E. Antonio Chiocca and Martine L.M. Lamfers
Received: 28 July 2015 / Revised: 30 December 2015 / Accepted: 6 January 2016 / Published: 12 January 2016
(This article belongs to the Special Issue Oncolytic Viruses)
View Full-Text   |   Download PDF [14701 KB, uploaded 12 January 2016]   |  


Oncolytic abilities of vaccinia virus (VACV) served as a basis for the development of various recombinants for treating cancer; however, “natural” oncolytic properties of the virus are not examined in detail. Our study was conducted to know how the genetically unmodified L-IVP strain of VACV produces its antitumor effect. Human A431 carcinoma xenografts in nude mice and murine Ehrlich carcinoma in C57Bl mice were used as targets for VACV, which was injected intratumorally. A set of virological methods, immunohistochemistry, light and electron microscopy was used in the study. We found that in mice bearing A431 carcinoma, the L-IVP strain was observed in visceral organs within two weeks, but rapidly disappeared from the blood. The L-IVP strain caused decrease of sizes in both tumors, however, in different ways. Direct cell destruction by replicating virus plays a main role in regression of A431 carcinoma xenografts, while in Ehrlich carcinoma, which poorly supported VACV replication, the virus induced decrease of mitoses by pushing tumor cells into S-phase of cell cycle. Our study showed that genetically unmodified VACV possesses at least two mechanisms of antitumor effect: direct destruction of tumor cells and suppression of mitoses in tumor cells. View Full-Text
Keywords: vaccinia virus; genetically unmodified L-IVP strain; human A-431 carcinoma xenografts; murine Ehrlich carcinoma; VACV-induced arrest of mitoses vaccinia virus; genetically unmodified L-IVP strain; human A-431 carcinoma xenografts; murine Ehrlich carcinoma; VACV-induced arrest of mitoses

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Zonov, E.; Kochneva, G.; Yunusova, A.; Grazhdantseva, A.; Richter, V.; Ryabchikova, E. Features of the Antitumor Effect of Vaccinia Virus Lister Strain. Viruses 2016, 8, 20.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top